PURAPHARM (01498) announced that, effective April 27, 2026, Mr. Li Jiahui has been appointed as an Independent Non-Executive Director, as well as a member of the Board Audit Committee, the Board Remuneration Committee, and the Board Nomination Committee. Professor Wu Hongwei has been appointed as an Independent Non-Executive Director and a member of the Audit Committee, the Remuneration Committee, and the Nomination Committee.